Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03TAY
|
||||
| Former ID |
DNCL003300
|
||||
| Drug Name |
VGX-3400
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Influenza A virus H5N1 [ICD9: 487, 488; ICD10:J10, J11] | Phase 1 | [1] | ||
| Company |
Inovio Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Hemagglutinin | Target Info | [2] | ||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01142362) Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults. U.S. National Institutes of Health. | ||||
| REF 2 | Clinical pipeline report, company report or official report of Inovio Pharmaceuticals. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.